Financials
- Market Capitalization 1.69 B
- Employee 14 K
- Founded 2023
- CEO Paul R. N. Kirchgraber
- Website www.fortrea.com
- Headquarter North Carolina, United States
- FIGI BBG01GZF9VY6
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2074 | SEPN Septerna, Inc. - Common Stock | 37.86 USD | -0.76% | -6.66% | +9.90% | +72.01% | 1.77 B USD | ||
| 2098 | GHRS GH Research PLC - Ordinary Shares | 27.49 USD | +1.89% | -4.65% | -2.41% | +94.14% | 1.71 B USD | ||
| 2125 | NVAX Novavax, Inc. - Common Stock | 10.03 USD | +7.04% | +6.25% | +36.28% | +35.72% | 1.65 B USD | ||
| 2128 | FBRX Forte Biosciences, Inc. - Common Stock | 76.99 USD | 0.00% | +0.04% | +0.40% | +162.32% | 1.63 B USD |